Hogan & Hartson
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of the Chief Counsel Senior Drugs Attorney and Supervisor David Fox joins D.C. law firm as partner. Fox was named FDA senior drugs attorney in 1997; he joined the agency in 1994. During his tenure, Fox was highly involved in OTC drug regulation, providing input during the drafting of the OTC labeling final rule and sitting in on several subsequent feedback meetings. Fox played a significant role in the development of FDA's final rule on tobacco products; the high-profile issue is receiving renewed attention after an agency-commissioned panel sent a report to FDA suggesting the agency regulate the manufacture, marketing and labeling of such items
|
FDA Office of the Chief Counsel Senior Drugs Attorney and Supervisor David Fox joins D.C. law firm as partner. Fox was named FDA senior drugs attorney in 1997; he joined the agency in 1994. During his tenure, Fox was highly involved in OTC drug regulation, providing input during the drafting of the OTC labeling final rule and sitting in on several subsequent feedback meetings. Fox played a significant role in the development of FDA's final rule on tobacco products; the high-profile issue is receiving renewed attention after an agency-commissioned panel sent a report to FDA suggesting the agency regulate the manufacture, marketing and labeling of such items. |